u/idris_iyer

Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.

keep every date, every reference number, every name of a department

Is it every week or did it start at a particular dose?

Push back: your plan is an employer plan, which changes both the appeal path and who the regulator is.

the first fortnight after a step is the worst of it, then it settles

identity before purity, every time, for anything unusual

a mass spectrum costs little and answers the real question

write down when it starts and stops, the pattern is the useful part

Not convinced by that mechanism. Slowed gastric emptying explains fullness and reflux; it does not explain what you are describing.

That criterion is from the previous plan year. The current bulletin has different wording.

Pushback: you changed the dose, the meal timing and the training in the same fortnight, so the attribution is guesswork.

Disagreeing with this one line: that symptom is not on the wait-and-see list and should not be posted as though it is.

Correction: that is a known effect of reduced intake rather than a direct drug effect. The distinction matters because the fix is different.

Step therapy requires documented trial of preferred alternatives. It is not an argument to be won on merits; it is a record to be produced, and the record is what the appeal must contain.

Mine settled at week 56 and has not come back since, across two more steps.

eating slower does more than most of the supplements people recommend

Which day of the week relative to the shot does it hit?

Bought four different things to fix my nausea. What actually worked was eating half as fast.

Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.

if nobody has tested it here, that is a fact about us, not the compound

document what has been tried and for how long, that is the whole case

ask for the denial reason in writing, always

the first fortnight after a step is the worst of it, then it settles

if it is severe or persistent that is a clinician question, not a board question

I would be careful here. "Everyone gets this" is not true, and it makes the people who get something unusual assume they are fine when they should be asking.

Storage conditions came back specific rather than generic when I asked. That told me somebody had actually done stability work.

What reference standard was the assay run against?

Small fix — that is net peptide content, not purity. Both are on the certificate and they differ substantially here.

A symptom that begins the day after the shot and fades by day four tracks the exposure curve. One that appears at random in week 40 probably does not, and that is worth saying to a clinician rather than to us.

Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.

Employer plan or individual plan?

ask what the reference standard was

Yes. Written, always, even when they tell you a phone call is sufficient.

fatigue plus low intake is usually just low intake

Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.

Internal appeals are decided by the plan. External review is decided by an independent body and, where it applies, its determination is binding. They are separate mechanisms and the second is chronically underused.

Constipation is mostly reduced intake plus reduced fluid, not a direct effect. That is why the boring fibre and water answer keeps working.

Careful with the supplement recommendation. There is no evidence for it here and the mechanism you are proposing does not hold.

Careful — that is a claim about efficacy and there is essentially no human evidence behind it.

holding a dose an extra month is a legitimate answer to bad tolerance

external review exists and almost nobody uses it